Showing 1 - 10 of 13
Case for SET reform
Oped, Postbag, Published on 08/12/2025
» Re: "Thai bourse seeks to jump start growth", (Business, Dec 6).
No Thatcher, is she
Oped, Postbag, Published on 28/07/2025
» Re: "Wartime requires a prime minister with full authority, (InQuote, July 25).
Stepping up HIV fight
Oped, Editorial, Published on 30/06/2025
» The recent news of Gilead Sciences' groundbreaking new HIV preventative drug, Lenacapavir, offers a beacon of hope in the fight against HIV. With a remarkable 96% efficacy in reducing HIV infection and the convenience of only two injections per year, Lenacapavir holds the potential to be a true game-changer in the global effort to halt the transmission of HIV.
Fed's rate rises might have way to go yet
Oped, Chartchai Parasuk, Published on 28/07/2022
» By the time this article is published, readers will know how much the US Fed funds rate has been raised for the fourth time this year. It does not really matter whether the rate is raised by 0.75% or 1% this time because the Fed will need to keep raising the rate (FFR) until it can effectively control inflation.
Tip of the iceberg
Oped, Postbag, Published on 25/02/2022
» Re: "ATK answer," (PostBag, Feb 23). Khun Burin Kantabutra has always proposed many novel ideas in the Post. However, I beg to politely differ with his suggestion in "ATK answer" for a disease which is already basically everywhere in the kingdom.
Beyond our winter of discomfort
Oped, Mohamed A. El-Erian, Published on 04/02/2022
» The start of 2022 has been marked by a deepening sense of unease, and not just within governments as they confront challenges relating to health, the economy, geopolitics, and, in some cases, national and financial security.
Covid-19 and the structural crises of our time
Oped, Lim Mah Hui & Michael Heng Siam-Heng, Published on 07/09/2021
» The Covid-19 pandemic devastating as it is not simply a health crisis. It is the product of an interlocking web of diverse problems that have been building up over time. Given the structural nature of this crisis, even as the embers of the immediate fire of infections and deaths burn out, the fallout from the conflagration will continue, taking different forms in its wake, including the rise of yet another pandemic.
Thailand's place in Big Pharma
Oped, Pasu Decharin, Published on 30/07/2021
» Names of medicines, vaccines and pharmaceutical companies have seeped into daily conversations. In the past, people cared so little about exact names of vaccines, injections or pills that they were given, not to mention details of manufacturer or even their locations. That has all changed thanks to the Covid-19 pandemic, which has triggered a shift in medication-taking behaviours. Names of the world's largest pharmaceutical companies, most of which are concentrated in the United States, followed by China, Japan, and European countries, have become more widely known, with the most familiar being Roche, Novartis, Merck, and Bristol Myers Squibb.
Submarines, or schools?
Oped, Editorial, Published on 01/06/2021
» Parliament yesterday kicked off its three-day deliberations on the budget bill for the next fiscal year, with a big question mark hanging over it. What should the government's priority be next year -- submarines or schools?
Can govt rise to jab roll-out challenge?
Oped, Sirinya Wattanasukchai, Published on 21/05/2021
» The colossal vaccine rollout plan in Bangkok -- 10 million doses to inoculate five million people over two months -- shows how the government has finally come to its senses that the only way to revive the economy is to create herd immunity as soon as possible.